Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Pulmonary Medicine

Reuters reports that Amgen Inc. has shown that their new drug, from a new class of inhibitors called PCSK9, is effective in lower levels of low-density lipoproteins (LDL). The clinical trial was the first of its kind to test the drug over a 52 week...
Cardiovascular events are almost three times more likely to occur in the morning than at any other time a day, but now scientists may have found a way to lower this statistic, The New York Times’ Well blog reports. The findings were presented at...
Previous studies have shown that childhood cancer may be linked to heart problems later in life, but a new study is the first to show that these risks may appear even when the patient is still a child. The New York Times’ Well blog reports on a...